CytoSorbents Corp (CTSO)
0.9399
+0.04
(+4.43%)
USD |
NASDAQ |
Dec 27, 16:00
0.9063
-0.03
(-3.57%)
After-Hours: 20:00
CytoSorbents SG&A Expense (Quarterly): 7.827M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Delcath Systems Inc | 6.953M |
| Star Equity Holdings Inc | 7.415M |
| Exact Sciences Corp | 411.90M |
| Illumina Inc | 239.00M |
| Progyny Inc | 46.79M |